For example, the antiarrhythmic drug procainamide, which also acts as an inhibitor of DNMT1, protects against diabetes by restoring the expression of the homeobox PDX1 (Pancreatic and duodenal homeobox 1) gene via a decrease in its methylation levels in β cells [94]. Here, PDX1 is linked to diabetes mellitus.